Clinical Trials Sponsored by Giacomo Fabbri

Total 207 results

Pierre Fabre Medicament

Completed

Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

Alveolar Osteitis

France, Lithuania, Latvia, Estonia
Pierre Fabre Medicament

Completed

Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy.

Open Cracked Heel in Diabetic Patients With Polyneuropathy

France, Belgium
Pierre Fabre Medicament

Completed

Assessment of V0018 1.5 mg Effect on Craving

Smoking

France
Pierre Fabre Medicament

Completed

Bronchodilator Properties and Safety in Asthma

Asthma

Germany
Pierre Fabre Medicament

Completed

Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

Iron Deficiency Anemia

Romania
Pierre Fabre Medicament

Completed

Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia

Drug-induced Xerostomia

Germany
Pierre Fabre Medicament

Completed

A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome

Fibromyalgia Syndrome

Spain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden, Denmark, Poland, United Kingdom
Pierre Fabre Medicament

Completed

Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

Fibromyalgia Syndrome

Switzerland
Pierre Fabre Medicament

Completed

Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations

Healthy Volunteers

Belgium
Pierre Fabre Medicament

Completed

Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy

Lung Cancer

France
Pierre Fabre Medicament

Withdrawn

Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis (VESTA)

Knee Osteoarthritis
Pierre Fabre Medicament

Completed

Brain Imaging Study of F17464

Healthy Volunteers

United States
Pierre Fabre Medicament

Completed

Nicotine Patch Safety Study

Smokers

France
Pierre Fabre Medicament

Completed

Acute Sore Throat Pain Study

Acute Sore Throat Pain

United Kingdom, France, Germany
Pierre Fabre Pharma GmbH
iOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment (BERING-CRC)

Metastatic Colorectal Carcinoma

Austria, Germany
Pierre Fabre Pharma GmbH
iOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Active, not recruiting

Real-life Pan-HER-blockade With Neratinib (ELEANOR)

Breast Neoplasm

Austria, Germany, Switzerland
UNICANCER
Pierre Fabre Medicament

Recruiting

A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer (COBRAF)

Metastatic Colorectal Cancer | BRAF V600E Mutation Positive

France
Pierre Fabre Dermo Cosmetique

Completed

Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream

Anti-aging

France
Pierre Fabre Dermo Cosmetique

Completed

Assessment of a Cosmetic Product Effect on the Host/Microorganism Relationship in Acneic Subjects

Acne

France
Pierre Fabre Dermo Cosmetique

Terminated

Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD

Dermatitis, Atopic

France
Pierre Fabre Dermo Cosmetique

Completed

Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year

Acne Vulgaris

France, Italy, Poland
Pierre Fabre Dermo Cosmetique

Completed

Assessment of the Wound Healing Efficacy and Tolerance of a Medical Device on Wounds in Healthy Subjects.

Healthy

Germany
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women

Telogen Effluvium

France
Pierre Fabre Dermo Cosmetique

Completed

Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women

Telogen Effluvium

France
Pierre Fabre Dermo Cosmetique

Withdrawn

Identification of Biomarkers and Characterization of Melasma

Chloasma
Pierre Fabre Medicament
ClinSearch

Withdrawn

Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema (CARING)

Chronic Hand Eczema
Pierre Fabre Pharma AG

Completed

Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). (Real-CHOICE)

Iron-Deficiency Anemia | Iron-Deficiency

Switzerland
Pfizer
Pierre Fabre Laboratories

Active, not recruiting

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Advanced Solid Tumors | Metastatic Melanoma

United States, Spain, Belgium, Canada, Netherlands
Pierre Fabre Medicament
Clinact

Completed

A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) (CAPSTAN CRC)

Metastatic Colorectal Cancer | BRAF V600E Mutation Positive

France, United Kingdom, Spain, Belgium, Germany, Italy, Austria
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product on Xerosis Induced by Systemic Anticancer Treatments

Xerosis

France
Pierre Fabre Dermo Cosmetique

Completed

IN-USE TOLERANCE STUDY UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS AND EFFICACY ASSESSMENT (Face Cream)

Hypersensitive | Reactive and Intolerant Skin | Redness-prone Skin | Stinger Subjects

China
Pierre Fabre Medicament
Biotrial

Active, not recruiting

Relative Bioavailability of Binimetinib 3 x 15 mg and 45 mg Formulations

Melanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

France
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin

Acne

France
Pierre Fabre Dermo Cosmetique

Completed

An Exploratory Study to Assess the Efficacy of the Avène Hydrotherapy (PAP)

Chronic Pruritus Due to Plaque Psoriasis

Spain, France
Pierre Fabre Dermo Cosmetique

Completed

Demonstration of Carbonyl Stress on Hair Follicles

Effluvium; Telogen

France
Jens Faber

Completed

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF) (LIHFA)

Heart Failure | Low T3 Syndrome

Denmark
Jens Faber

Completed

LIPT - Liraglutide in Polycystic Ovary Syndrome (LIPT)

Cardiovascular Disease | Polycystic Ovary Syndrome

Denmark
Pierre Fabre Dermo Cosmetique

Completed

Avene Compact Honey for Prevention of Pigmentation From Visible Light

Healthy

Canada
Dr. R. Pfleger Chemische Fabrik GmbH

Completed

Pharmacokinetic Interaction Between Trospium With an Inhibitor of OCT1 and of P-gp in Subjects Genotyped for OCT1

Pharmacokinetics | Drug Interaction Potentiation | Inhibition Enzyme
Centro de Investigaciones Medicas y Ensayos Clinicos...
CALOX Laboratories; Bioanalisis

Unknown

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study (BETAGENWART)

Genital Wart Virus Infection

Nicaragua
Pierre Fabre Dermo Cosmetique

Not yet recruiting

Evaluation of the Tolerance of the Medical Device RL3010A - DP0378 in Children and Adults Presenting a Superficial Wound After a Dermatological Procedure

Skin Abrasion | Superficial Wound
Pierre Fabre Dermo Cosmetique

Not yet recruiting

Evaluate the Efficacy and the Tolerance of the Medical Device V063B-DP3003 on Dentin Hypersensitivity During Teeth Whitening

Tooth Whitening
Pierre Fabre Dermo Cosmetique

Completed

Re-epithelialization Efficacy Evaluation of Cosmetic Product RV1551P vs Non-treated Forearm of Healthy Adult Women

Healthy

France
Pierre Fabre Dermo Cosmetique

Completed

Photoprotective Effects of a SPF50+ Sunscreen on Skin Genotoxicity Induced by Repeated Chronic Outdoor Sun Exposure

Sun Damaged Skin

France
Pierre Fabre Dermo Cosmetique

Completed

Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method

Sunscreen

France
Pierre Fabre Medicament
Biotrial

Completed

Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations

Melanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

France
Pfizer
Pierre Fabre Laboratories

Terminated

Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma

Melanoma

Italy
Pierre Fabre Medicament
Clinact

Completed

Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial

Actinic Keratoses

France, Germany, Italy, Spain
Pierre Fabre Dermo Cosmetique

Completed

IN-USE TOLERANCE STUDY UNDER DERMATOLOGICAL AND OPHTHALMOLOGICAL CONTROLS AND EFFICACY ASSESSMENT (Face Balm)

Hypersensitive | Reactive and Intolerant Skin | Redness-prone Skin | Stinger Subjects

China
Pierre Fabre Dermo Cosmetique

Completed

Sunscreen Efficacy Against the Reccurence of Lesions Post-sun Exposure in Acneic Subjects

Acne

Portugal

3

Subscribe